{"id":156608,"date":"2024-04-27T11:44:39","date_gmt":"2024-04-27T11:44:39","guid":{"rendered":"https:\/\/dailytalks.org\/?p=156608"},"modified":"2024-04-27T11:44:39","modified_gmt":"2024-04-27T11:44:39","slug":"current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=156608","title":{"rendered":"Current antiviral treatment course is inadequate for high-risk COVID-19"},"content":{"rendered":"<p>Molnupiravir&#8217;s impact on SARS-CoV-2 response in at-risk outpatients.<br \/>\nContinue reading Current antiviral treatment course is inadequate for high-risk COVID-19 on Tech Explorist&#8230;<br \/><a href=\"https:\/\/www.techexplorist.com\/current-antiviral-treatment-course-inadequate-high-risk-covid-19\/81520\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Molnupiravir&#8217;s impact on SARS-CoV-2 response in at-risk outpatients. Continue reading Current antiviral treatment course is<\/p>\n","protected":false},"author":1,"featured_media":156609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[],"class_list":["post-156608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19.jpg",1280,853,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-300x200.jpg",300,200,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-768x512.jpg",640,427,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-1024x682.jpg",640,426,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19.jpg",1280,853,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19.jpg",1280,853,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-1024x682.jpg",1024,682,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/156608-current-antiviral-treatment-course-is-inadequate-for-high-risk-covid-19-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=43\" rel=\"category\">Health<\/a>","tag_info":"Health","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/156608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=156608"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/156608\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/156609"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=156608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=156608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=156608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}